CDX1 is an important molecular mediator of Barrett's metaplasia
about
Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesisGenetic susceptibility to Barrett's oesophagus: Lessons from early studiesMolecular changes in the progression of Barrett's oesophagusMultilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers.Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagusHistory, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome.Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia.Pinin modulates expression of an intestinal homeobox gene, Cdx2, and plays an essential role for small intestinal morphogenesis.Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.Biology of Barrett's esophagus and esophageal adenocarcinomaReview: Experimental models for Barrett's esophagus and esophageal adenocarcinomaThe CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiationBarrett esophagus: history, definition and etiopathogenyBarrett's Esophagus: Emerging Knowledge and Management StrategiesMethylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach.Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis.Molecular basis of Barrett's oesophagus and oesophageal adenocarcinomaRelationships of CDXs and apical sodium-dependent bile acid transporter in Barrett's esophagus.Genetic instability is not a requirement for tumor development.Esophageal adenocarcinoma arising in Barrett esophagusAcid, bile, and CDX: the ABCs of making Barrett's metaplasia.The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival.Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia.Barrett's esophagus: can biomarkers predict progression to malignancy?Investigating the fixation and spread of mutations in the gastrointestinal epithelium.Single nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus.Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia.Molecular mechanisms of Barrett's esophagus.Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesisBiomarkers in Barrett's oesophagus and oesophageal adenocarcinoma.1,25-dihydroxyvitamin D in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.Hacking cell differentiation: transcriptional rerouting in reprogramming, lineage infidelity and metaplasiaThe esophageal mucosa and submucosa: immunohistology in GERD and Barrett's esophagus.Epigenetics in esophageal cancers.Differential gene expression in normal esophagus and Barrett's esophagus.Transcommitment: Paving the Way to Barrett's Metaplasia.
P2860
Q24651576-6B823054-C40C-403E-B8F0-47D6A898C952Q24683173-72ACC767-83AE-432A-96E2-4469DBA33255Q26740556-AE4EE02F-37C3-47A7-8FED-FDD8E488BA72Q28219148-470D2697-5517-4C4F-93DF-C06141F51548Q33314440-A7481CDF-F412-4613-8A27-C1E4FBE0810EQ33379614-3512BF13-5F8B-497E-B79B-C67BBAA2FC02Q33786336-1BBDB901-5020-49F5-A6E5-FD0F621C4A6BQ33816773-15EF4F09-DB38-4FAA-B02D-7041ADD65427Q33987356-3F1E69DB-D9DA-43B7-B13D-A0497427EF75Q34117556-6B782F31-9122-4FB8-8E1B-D660C59CBD67Q34170531-C8182B99-10E4-406D-941C-3FCA7C7C3776Q34393702-9C4456C9-6610-444D-9635-86ACB2B62BC5Q34644324-492946A7-AF04-46BE-83FE-00CADA3D33C3Q35235311-FE2ED24F-79B9-4D3A-BE44-C65F1F87A1FAQ35280248-7C32DBC0-0A4D-490B-9745-13EE30E4D563Q35340490-AA31E47A-15FF-4B5B-A0EA-F5259EB856E4Q36014649-82BFA537-3EF5-4F70-ADEE-211C80ADFC07Q36131557-96C3C527-A170-4B44-AA8F-2154814CE758Q36163408-1C781D78-FF01-4291-AFEA-34DD26273E75Q36662322-E7897BE9-3965-4A08-8F38-BA3383A94D3AQ36841300-C99BF6C1-0D7E-481E-A141-456ABDDBE967Q37165110-4D051B57-43CE-469F-94AB-84AD1EAFC299Q37169303-C8202695-E631-4B19-B2D4-374E65FEB28EQ37192028-825EDB82-DA73-48BB-AB5C-087ABB644576Q37227732-4B7F5CFF-DCDA-4A95-A958-5B76239896ADQ37249748-E5ED3EC7-ED29-4C01-975D-FC654EE402DDQ37345836-222CD83D-3226-4EEB-8E78-C74B1B41D237Q37352013-9700D69B-6719-4508-AA68-488EA0082444Q37625982-6B3004DC-C683-4DB3-BF4C-CE3B683F7252Q37809363-F8C5AF16-77CE-4FC8-928F-584852390774Q37880176-B57022B1-3101-49DD-A45C-EB87AAB16721Q37943774-8C86031E-BF2A-417C-A46D-19D0DF85B85FQ38006676-0BC94543-5E16-424F-9008-8414B94D6018Q38089259-534448BC-D30A-4EFE-B438-CF7BA000FEBDQ38111420-752B7B22-D15B-4FC4-8CA4-FC132A97F444Q38119462-4F55195B-C1B0-4EEE-8934-CF9125DF5CFEQ38151812-1E41079D-F5CD-4D4D-A270-CB4F582E1072Q38210930-EB39665A-E060-46CD-9F6F-67F8CBFCAF83Q38353766-D6DBC4B0-9B56-4514-A618-5507E4EDE77BQ38940526-EFFB4837-45D7-4EB6-855F-9AD4BE59653B
P2860
CDX1 is an important molecular mediator of Barrett's metaplasia
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
CDX1 is an important molecular mediator of Barrett's metaplasia
@ast
CDX1 is an important molecular mediator of Barrett's metaplasia
@en
CDX1 is an important molecular mediator of Barrett's metaplasia
@en-gb
CDX1 is an important molecular mediator of Barrett's metaplasia
@nl
type
label
CDX1 is an important molecular mediator of Barrett's metaplasia
@ast
CDX1 is an important molecular mediator of Barrett's metaplasia
@en
CDX1 is an important molecular mediator of Barrett's metaplasia
@en-gb
CDX1 is an important molecular mediator of Barrett's metaplasia
@nl
prefLabel
CDX1 is an important molecular mediator of Barrett's metaplasia
@ast
CDX1 is an important molecular mediator of Barrett's metaplasia
@en
CDX1 is an important molecular mediator of Barrett's metaplasia
@en-gb
CDX1 is an important molecular mediator of Barrett's metaplasia
@nl
P2093
P2860
P3181
P356
P1476
CDX1 is an important molecular mediator of Barrett's metaplasia
@en
P2093
Bartlett S
Marshall R
P2860
P304
P3181
P356
10.1073/PNAS.0502031102
P407
P577
2005-05-13T00:00:00Z